Navigation Links
Lpath to Present at 34th Annual Canaccord Genuity Growth Conference
Date:8/11/2014

SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, today announced that Scott Pancoast, president and CEO, will present at the 34th Annual Canaccord Genuity Growth Conference on Wednesday, August 13, 2014 at 5:00 p.m. Eastern Time in Boston. The live webcast presentation and replay will be available by visiting the Investor section of the Lpath website at www.Lpath.com.

About Lpath
San Diego-based Lpath, Inc. (NASDAQ: LPTN), an antibody-platform company, is the category leader in lipid-targeted therapeutics. The company's ImmuneY2™ drug-discovery engine has the unique ability to generate therapeutic antibodies that bind to and inhibit bioactive lipids that contribute to disease. The company has developed four drug candidates, two of which – iSONEP™ for wet AMD and ASONEP™ for cancer—are currently being investigated in Phase 2 trials. The other candidates are an anti-lysophosphatidic acid antibody, LpathomabTM, which is expected to enter the clinic in 2015 for neuropathic pain and neurotrauma, and an anti-leukotriene antibody, AltepanTM, which is being studied in models of respiratory disease. For more information, visit www.Lpath.com.


'/>"/>
SOURCE Lpath
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
2. Lpath Withdraws From Pfizers Process to Assign iSONEP Rights
3. Genomic Health to Present at the Canaccord Genuity 34th Annual Growth Conference
4. Lexicon To Present At The 2014 Wedbush Life Sciences Management Access Conference
5. Omeros to Present at the Wedbush PacGrow 2014 Life Sciences Management Access Conference
6. Guardant Health to Present at the WedBush 2014 Life Sciences Management Access Conference
7. Mast Therapeutics To Present At The Canaccord Genuity 34th Annual Growth Conference On August 14th
8. STAAR Surgical To Present At Wedbush And Canaccord Investor Conferences
9. KemPharm, Inc. to Present at the Canaccord Genuity 34th Annual Growth Conference
10. MEI Pharma To Present At Wedbush PacGrow Life Sciences And Canaccord Genuity Growth Conferences
11. Cynosure to Present at Canaccord Genuity 34th Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... , Feb. 21, 2017 Medical Oxygen ... report: http://www.reportlinker.com/p04711311-summary/view-report.html Medical oxygen concentrators ... other respiratory diseases. Patients having low level of ... oxygen concentrators. Oxygen concentrators are to be used ... the counter. Medical oxygen concentrators work either on ...
(Date:2/21/2017)... , Feb. 21, 2017   BeyondSpring Pharmaceuticals ... the development of innovative immuno-oncology cancer therapies, today ... data from its Phase 2 trial of BeyondSpring,s ... treatment of non-small cell lung cancer (NSCLC) with ... this year,s ASCO-SITC Clinical Immuno-Oncology Symposium in ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... ... of African American/Black students who want to become physicians. PMF also provides a ... as physicians in the Oakland/San Francisco Northern California, Bay Area. PMF’s mission is ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... Marc Philpart, senior director at PolicyLink, will be the keynote speaker at its ... Boys and Men of Color Framework, which develops comprehensive strategies to create and ...
(Date:2/21/2017)... ... ... Ray Insurance Agencies, a Dallas area firm providing asset protection services and ... six month charity event aimed at raising local support and donations that will be ... deadliest diseases in America; more than 7.5 million people die from cancer related disorders ...
(Date:2/21/2017)... ... February 21, 2017 , ... Each February ... History Month (officially African American History Month ). This month-long ... of a diverse race of people, but also the opportunity to examine the ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
Breaking Medicine News(10 mins):